Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomasAndreas H. Scheel, Reinhard Buettner|Modern Pathology|2016Cited by 347
<scp>NOTCH</scp>, <scp>ASCL1</scp>, p53 and <scp>RB</scp> alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomasLydia Meder, Reinhard Buettner|International Journal of Cancer|2015Cited by 177
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Martin L. Sos, Johannes Brägelmann et al.|Science Translational Medicine|2017Cited by 64